BIO 株価分析 — BIO-RAD LABORATORIES INC (Healthcare >> Medical Devices)
BIO に関するよくある質問
BIOのPER(株価収益率)は?
BIO-RAD LABORATORIES INC(BIO)は現在PER 8.43倍で取引されています。
BIOのROE(自己資本利益率)は?
BIO-RAD LABORATORIES INCのROEは2.46%です。
BIOの配当利回りは?
BIO-RAD LABORATORIES INCの配当利回りは0.00%です。
BIOの品質スコア(Quality Score)は?
当社のAIはBIOの総合財務品質を100点中23点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
BIOは今が買い時ですか?
当社AIのタイミングスコアは100点中91点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
BIOはどのセクターに属しますか?
BIO-RAD LABORATORIES INCはHealthcare >> Medical Devicesセクターに分類されます(NYSE市場)
BIO AI Analysis Summary
Our AI summary for BIO: BIO-RAD LABORATORIES INC (NYSE), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 8.43, ROE of 2.46%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 325.48
Price
-1.24
(-0.38%)
Day Change
|
|
|---|
BIO, ファンダメンタルスコアはnot good ( ファンダメンタル = 23) but テクニカルスコアは ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROEが昨年度比で低い
ROAの伸びが低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 44 |
| Magic Formula Rank by ROA |
432
|
| Magic Formula Rank by ROE |
432
|
| Magic Formula Rank by ROIC |
544
|
| Price | 325.48 |
| PBV / Sector |
1.28 / -101.57
GOOD
|
| Earning Per Share | 6.28 |
| PE / Sector |
8.43 / 31.23
GREAT
|
| PEG or PE/Growth / Sector |
-1.01 / 0.40
|
| Average 1M Daily Value |
79.41 M
|
| Average 1W Daily Value |
98.70 M
|
| Timing Factors |
|
42% |
| Financial Health |
|
58% |
| ポイントになる統計 |
|
52% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-01 07:59:33 |
| Symbol | BIO |
| Name | BIO-RAD LABORATORIES INC |
| Sector | Healthcare >> Medical Devices |
| Market | NYSE |
| Listed Shares | 21.70 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 8,743.55 / 20,104.97 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547
Phone: 510 724 7000
Website: https://www.bio-rad.com
Employees: 7,450
Sector: Healthcare >> Medical Devices
Description: Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
Google